Clinical Trial Update: Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing oxymatrine plus lamivudine to lamivudine alone in chronic hepatitis B has completed. The study was sponsored by Southeast University, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Lamivudine (lamivudine)
• Oxymatrine (oxymatrine)

Snippet

Sponsor: Southeast University, China | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED